作為一家從事生命科學(xué)和體外診斷行業(yè)的俄羅斯私有企業(yè),XEMA有限公司(原Xema-Medica有限公司)始建于1993年2月,總部設(shè)在莫斯科。
公司從一開始開展人類抗原合成的代工業(yè)務(wù),到現(xiàn)在公司已經(jīng)成為世界上的腫瘤標(biāo)志物抗原生產(chǎn)企業(yè)。我們廣泛收集雜交瘤細(xì)胞的業(yè)務(wù)確保我們能夠生產(chǎn)出大量用于體外診斷的純化單克隆抗體
截止到目前, 我們非常自豪可以在幾個(gè)主要研究課題的重點(diǎn)研究工作上保持著非常高的科研水準(zhǔn):
- 生物化學(xué)和人類腫瘤標(biāo)志物和獸藥標(biāo)志物免疫學(xué) [癌胚抗原(CEA),糖類抗原(CA 125),糖類抗原(CA 19 – 9),糖類抗原(CA 72 – 4),附膜蛋白(MUC1),細(xì)胞角蛋白等];
- 食物抗原的免疫化學(xué)(特別是谷物,肉類和魚類醇溶蛋白);
- 真菌性抗原的研究以及對(duì)食品和環(huán)境真菌污染評(píng)估的免疫開發(fā)研究。
XEMA新產(chǎn)品列表:
產(chǎn)品目錄編號(hào) | 產(chǎn)品名稱 | 檢測(cè)的數(shù)量 | 產(chǎn)品英文名稱 | 樣品量,微升 | 靈敏度 | 階段編號(hào) | 培育時(shí)間,分鐘 | 培育溫度 | 保質(zhì)期,月 | 方法 | 版本 | CE注冊(cè)號(hào) |
K930 | SULPHONAMIDE EIA | 96 | Sulphonamides are widely used in agriculture as potent and effective f> | 50 | 0,5 ?g/l | 2 | /60/60/10-20' | 37?C | 12 | ??? | 002 | 0 |
K902 | Laevomycetin (Chloramphenicol) EIA | 96 | Laevomycetin (Chloramphenicol) is a potent antibiotic drug which is wi> | 50 | 0,035 ?g/l | 1 | //60/25-35' | 37 ?C | 12 | ??? | 909 | 0 |
K101M | Toxoplasma IgM EIA | 96 | TToxoplasmosis is a widespread infection caused by the intracellular p> | 10 | K | 2 | 60//30/10-20' | 37 ?C | 12 | ??? | 906 | 0 |
K102M | Rubella IgM EIA | 96 |
| 10 | K | 2 | 60//30/10-20' | 37 C | 12 | EIA | 003 | 0 |
K103M | Cytomegalovirus IgM EIA | 96 |
| 10 | K | 2 | 60//30/10-20' | 37 C | 12 | EIA | 906 | 0 |
K104M | HSV 1, 2 IgM EIA | 96 |
| 10 | K | 2 | 60//30/10-20' | 37 C | 12 | EIA | 906 | 0 |
K151C | Parvo-IgG EIA | 96 | Parvovirus genus includes several specii, the canidae Parvovirus (CPV)> | 100* | 5 U/ml | 2 | 30//30/10-20' | 37 ?C | 12 | ??? | 711 | 0 |
K152C | CDV-IgG EIA | 96 | canidae/mustelidae Distermer disease is caused by a virus of the Pramy> | 100* | 10 U/ml | 2 | 30//30/10-20' | 37 ?C | 12 | ??? | 711 | 0 |
K244 | CA72-4 EIA | 96 | CA72-4 is a carbohydrate antigen (an epitope) with a MM ca. 230 kD ass> | 10 | 2 U/ml | 2 | 120//60/10-20' | 37 ?C | 12 | ??? | 901 | 0 |
K279K | free K-chain EIA | 96 | Apart from normal immunoglobulins, free immunoglobulin light chains (k> | 40* | 1 ?g/ml | 2 | 30//30/10-20' | 37 ?C | 18 | ??? | 000 | 0 |
K279L | free L-chain EIA | 96 | Apart from normal immunoglobulins, free immunoglobulin light chains (k> | 40* | 0,1 ?g/ml | 2 | 30//30/10-20' | 37 ?C | 18 | ??? | 000 | 0 |
KQ23 | PrenaQon-Control | 2 levels x 2 pcs; 1 ml |
|
|
| 0 | ///-' | 0 | 36 | 0 | 510 | NO |
E235 | ?-HCG LIFA | 96 | Thyroid stimulating hormone (TSH) is a glycoprotein with molecular wei> | 50 | 0,5 ng/ml | 1 | //60/10-' | 37?C | 0 | ???? | 901 | 0 |
E238 | PAPP-A LIFA | 96 | Thyroid stimulating hormone (TSH) is a glycoprotein with molecular wei> | 50 | 20 mIU/l | 1 | //60/10-' | 37?C | 0 | ???? | 901 | 0 |
K236 | CYFRA 21-1 EIA | 96 | Antigen CYFRA 21-1 is an established name for the epitopes expressed o> | 50 | 1 ng/ml | 1 | //30/10-20' | 37 ?C | 12 | ??? | 912 | 0 |
K174CF | Nematoda IgG-CF EIA | 96 |
| 100* | K | 2 | 30//30/10-20' | 37 C | 12 |
| 002 | 0 |
K175CF | Eucestoda IgG-CF EIA | 96 |
| 100* | K | 2 | 30//30/10-20' | 37 C | 12 |
| 004 | 0 |
K200S | Specific IgE EIA | 96 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | 50 | 0,1 IU/ml | 3 | 60/60/30/10-20' | 18-25?C | 12 | ??? | 001 | 0 |
K200SCB | Specific IgE CB EIA | 16 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | 0 |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SP | Specific IgE P EIA | 96 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | 0 |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200ST | Specific IgE T EIA | 96 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | 0 |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200STx | Specific IgE-Tx EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SD1 | Specific IgE-D1 EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SE1 | Specific IgE-E1 EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SE2 | Specific IgE-E2 EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SGx | Specific IgE-Gx EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K200SW56 | Specific IgE-W56 EIA | 40 | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi> | * |
| 0 | ///-' | 0 | 12 | ??? | 001 | 0 |
K470 | CIC- | 96x4 | Immune complexes are clusters of interlocking antigens and antibodies.> | 20 | 0 | 1 | 120///-' | 18-25?C | 36 | ?? | 001 | 0 |
K201N | TSH-Neo EIA | 96 | TSH-Neo ELISA is intended for the quantitative determination of Thyroi> | 0 | 3 ?IU/ml | 2 | 12-18 ????? (????)//60/10-20' | 18-25?C | 12 | ??? | 001 | 0 |
#NBS | 0 | 3 c 1 |
| 0 |
| 0 | ///-' | 0 | 0 |
| 005 | 0 |
K111 | Treponema pallidum EIA | 96 |
| 40 | K | 2 | 30//30/15-30' | 37C | 12 |
| 000 | 0 |
電話
QQ咨詢
4006551678